JP2006505536A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006505536A5 JP2006505536A5 JP2004540158A JP2004540158A JP2006505536A5 JP 2006505536 A5 JP2006505536 A5 JP 2006505536A5 JP 2004540158 A JP2004540158 A JP 2004540158A JP 2004540158 A JP2004540158 A JP 2004540158A JP 2006505536 A5 JP2006505536 A5 JP 2006505536A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- protein
- patient
- peptide
- binding
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims 3
- 102000008857 Ferritin Human genes 0.000 claims 2
- 108050000784 Ferritin Proteins 0.000 claims 2
- 239000012503 blood component Substances 0.000 claims 2
- 208000031886 HIV Infections Diseases 0.000 claims 1
- 208000037357 HIV infectious disease Diseases 0.000 claims 1
- 101000799972 Homo sapiens Alpha-2-macroglobulin Proteins 0.000 claims 1
- 101000766306 Homo sapiens Serotransferrin Proteins 0.000 claims 1
- 102000008100 Human Serum Albumin Human genes 0.000 claims 1
- 108091006905 Human Serum Albumin Proteins 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 102000009488 Thyroxine-Binding Proteins Human genes 0.000 claims 1
- 108010048889 Thyroxine-Binding Proteins Proteins 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 102000049437 human A2M Human genes 0.000 claims 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 102000005963 steroid binding proteins Human genes 0.000 claims 1
- 108020003178 steroid binding proteins Proteins 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41279702P | 2002-09-24 | 2002-09-24 | |
| US60/412,797 | 2002-09-24 | ||
| PCT/US2003/029815 WO2004029201A2 (en) | 2002-09-24 | 2003-09-23 | Peptide derivative fusion inhibitors of hiv infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010105068A Division JP2010209097A (ja) | 2002-09-24 | 2010-04-30 | Ｈｉｖ感染のペプチド誘導体融合阻害剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006505536A JP2006505536A (ja) | 2006-02-16 |
| JP2006505536A5 true JP2006505536A5 (OSRAM) | 2006-11-09 |
| JP5385497B2 JP5385497B2 (ja) | 2014-01-08 |
Family
ID=32043189
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004540158A Expired - Lifetime JP5385497B2 (ja) | 2002-09-24 | 2003-09-23 | Ｈｉｖ感染のペプチド誘導体融合阻害剤 |
| JP2010105068A Pending JP2010209097A (ja) | 2002-09-24 | 2010-04-30 | Ｈｉｖ感染のペプチド誘導体融合阻害剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010105068A Pending JP2010209097A (ja) | 2002-09-24 | 2010-04-30 | Ｈｉｖ感染のペプチド誘導体融合阻害剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US7575750B2 (OSRAM) |
| EP (1) | EP1542718B1 (OSRAM) |
| JP (2) | JP5385497B2 (OSRAM) |
| CN (1) | CN1327897C (OSRAM) |
| AP (1) | AP2203A (OSRAM) |
| AU (2) | AU2003275116A1 (OSRAM) |
| BR (1) | BR0314657A (OSRAM) |
| CA (1) | CA2500248C (OSRAM) |
| CR (1) | CR7806A (OSRAM) |
| EA (1) | EA007918B1 (OSRAM) |
| ES (1) | ES2558680T3 (OSRAM) |
| IL (1) | IL167527A (OSRAM) |
| NZ (1) | NZ539539A (OSRAM) |
| WO (1) | WO2004029201A2 (OSRAM) |
| ZA (1) | ZA200503118B (OSRAM) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1479691T3 (da) | 2001-05-31 | 2007-03-12 | John Erickson | Langvarigt aktive fuionspeptidinhibitorer for HIV infektion |
| AU2003275116A1 (en) * | 2002-09-24 | 2004-04-19 | Frontier Biotechnologies Co., Ltd | Peptide derivative fusion inhibitors of hiv infection |
| CN100455594C (zh) * | 2005-12-14 | 2009-01-28 | 中国人民解放军军事医学科学院生物工程研究所 | 抑制hiv病毒融合的多肽及其用途 |
| CN1793170A (zh) * | 2005-12-14 | 2006-06-28 | 中国人民解放军军事医学科学院生物工程研究所 | 抑制hiv病毒融合的多肽及其用途 |
| EP1976876A4 (en) * | 2005-12-22 | 2010-01-13 | Conjuchem Biotechnologies Inc | PROCESS FOR PRODUCING PREFORMED ALBUMIN CONJUGATES AND THERAPEUTIC AGENT |
| WO2008144590A2 (en) * | 2007-05-16 | 2008-11-27 | Conjuchem Biotechnologies Inc. | Long lasting modified antifusogenic peptide for preventing hiv infection |
| WO2012022040A1 (zh) * | 2010-08-19 | 2012-02-23 | 清华大学 | Hiv-1病毒膜融合抑制剂及其应用 |
| CN103664701A (zh) * | 2013-11-29 | 2014-03-26 | 成都普康生物科技有限公司 | [2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸合成路线 |
| JP2022543956A (ja) * | 2019-05-07 | 2022-10-17 | フロンティア バイオテクノロジーズ インク． | 安定なアルブビルチド組成物 |
| CA3183791A1 (en) * | 2020-06-28 | 2022-01-06 | Zvika GRANOT | Neutrophil-binding peptides |
| CN115025218B (zh) * | 2021-07-30 | 2025-03-28 | 前沿生物药业(南京)股份有限公司 | 联用治疗人类免疫缺陷病毒的活性组合及其应用 |
| WO2024238349A1 (en) * | 2023-05-12 | 2024-11-21 | Frontier Medicines Corporation | Identification and characterization of protein sites |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3719667A (en) | 1970-08-24 | 1973-03-06 | Lilly Co Eli | Epimerization of 6-acylamido and 6-imido penicillin sulfoxide esters |
| US3840556A (en) | 1971-05-28 | 1974-10-08 | Lilly Co Eli | Penicillin conversion by halogen electrophiles and anti-bacterials derived thereby |
| US3791667A (en) * | 1972-05-04 | 1974-02-12 | H Haviland | Retractable vehicle passenger cushioning system |
| US5612034A (en) | 1990-10-03 | 1997-03-18 | Redcell, Inc. | Super-globuling for in vivo extended lifetimes |
| CA2106314A1 (en) | 1991-04-05 | 1992-10-06 | John P. Burnier | Platelet aggregation inhibitors having high specification for gpiibiiia |
| US5624902A (en) | 1995-06-07 | 1997-04-29 | Torrey Pines Institute For Molecular Studies | Peptide inhibitors of calmodulin |
| US6475491B1 (en) * | 1995-06-07 | 2002-11-05 | Trimeris, Inc. | Treatment of HIV and other viral infections using combinatorial therapy |
| US6268479B1 (en) | 1997-03-12 | 2001-07-31 | The Trustees Of Columbia University In The City Of New York | Intracellular amyloid-beta peptide binding (ERAB) polypeptide |
| US6281331B1 (en) | 1998-03-23 | 2001-08-28 | Trimeris, Inc. | Methods and compositions for peptide synthesis |
| US6258782B1 (en) * | 1998-05-20 | 2001-07-10 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| US6656906B1 (en) * | 1998-05-20 | 2003-12-02 | Trimeris, Inc. | Hybrid polypeptides with enhanced pharmacokinetic properties |
| JP4209086B2 (ja) * | 1999-05-17 | 2009-01-14 | コンジュケム バイオテクノロジーズ インコーポレイテッド | 長期持続性抗新脈管形成ペプチド |
| SI1180121T1 (en) * | 1999-05-17 | 2004-04-30 | Conjuchem, Inc. | Long lasting insulinotropic peptides |
| EP1623994A3 (en) * | 1999-05-17 | 2008-07-16 | ConjuChem Biotechnologies Inc. | Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| BR0010757A (pt) | 1999-05-17 | 2002-02-19 | Conjuchem Inc | Inibidores de peptìdeo de fusão de longa duração de infecção viral |
| US6750008B1 (en) * | 1999-07-09 | 2004-06-15 | Trimeris, Inc. | Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission |
| CN1172717C (zh) * | 2000-08-18 | 2004-10-27 | 清华大学 | 一种治疗艾滋病的药物及其制备方法 |
| AU2003275116A1 (en) * | 2002-09-24 | 2004-04-19 | Frontier Biotechnologies Co., Ltd | Peptide derivative fusion inhibitors of hiv infection |
-
2003
- 2003-09-23 AU AU2003275116A patent/AU2003275116A1/en not_active Abandoned
- 2003-09-23 EP EP03759385.2A patent/EP1542718B1/en not_active Expired - Lifetime
- 2003-09-23 EA EA200500533A patent/EA007918B1/ru not_active IP Right Cessation
- 2003-09-23 US US10/667,966 patent/US7575750B2/en not_active Expired - Lifetime
- 2003-09-23 AP AP2005003291A patent/AP2203A/xx active
- 2003-09-23 CA CA2500248A patent/CA2500248C/en not_active Expired - Lifetime
- 2003-09-23 BR BR0314657-0A patent/BR0314657A/pt not_active IP Right Cessation
- 2003-09-23 ES ES03759385.2T patent/ES2558680T3/es not_active Expired - Lifetime
- 2003-09-23 NZ NZ539539A patent/NZ539539A/en not_active IP Right Cessation
- 2003-09-23 WO PCT/US2003/029815 patent/WO2004029201A2/en not_active Ceased
- 2003-09-23 CN CNB038164345A patent/CN1327897C/zh not_active Expired - Lifetime
- 2003-09-23 JP JP2004540158A patent/JP5385497B2/ja not_active Expired - Lifetime
-
2005
- 2005-03-17 IL IL167527A patent/IL167527A/en active IP Right Grant
- 2005-04-18 ZA ZA200503118A patent/ZA200503118B/en unknown
- 2005-04-22 CR CR7806A patent/CR7806A/es unknown
-
2009
- 2009-09-25 US US12/567,250 patent/US8470527B2/en not_active Expired - Fee Related
-
2010
- 2010-03-04 AU AU2010200823A patent/AU2010200823B2/en not_active Ceased
- 2010-04-30 JP JP2010105068A patent/JP2010209097A/ja active Pending
-
2013
- 2013-06-25 US US13/926,698 patent/US20140187476A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003094849A3 (en) | Ferritin fusion proteins for use in vaccines and other applications | |
| BRPI0513959A (pt) | anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos | |
| JP2005527470A5 (OSRAM) | ||
| EP1127170A4 (en) | HUMAN MONOCLONAL ANTIBODIES TO HUMAN PAN-HEPATITIS C VIRUS | |
| AT500379B1 (de) | Tau-proteine | |
| JP2009537143A5 (OSRAM) | ||
| JP2005537234A5 (OSRAM) | ||
| WO2001096587A3 (en) | Methods for administering recombinant adeno-associated virus virions to humans previously exposed to adeno-associated virus | |
| NO20063926L (no) | N-terminale monopegylerte humane veksthormonkonjugater, fremgangsmater for fremstilling og anvendelse av disse | |
| AR035867A1 (es) | Una particula semejante a un virus hcv formada por una proteina de envoltura de hcv, un metodo para formar dicha particula, un medicamento que la contiene, una vacuna, un metodo de deteccion, un kit de diagnostico, el uso de cepas de hansenula o saccharomyces para la expresion de una proteina hcv, e | |
| JP2003500341A5 (OSRAM) | ||
| WO2000066173A3 (en) | Targeting of infectious agents bearing host cell proteins | |
| WO2004014936A3 (fr) | Melange de peptides issus des proteines c et ns3 du virus de l'hepatite c et leurs applications. | |
| JP2018510213A5 (OSRAM) | ||
| JP2004505113A5 (OSRAM) | ||
| JP2018502893A5 (OSRAM) | ||
| EP1504766A4 (en) | MEDICAMENT OR GENE SUPPORT COMPOSITION WITH HEMAGGLUTININ ACTIVITY | |
| NO20024325L (no) | Rensede hepatitt C-viruskappeproteiner for diagnose og terapeutisk anvendelse | |
| WO2004072233A3 (en) | Hiv-specific fusion proteins and therapeutic and diagnostic methods for use | |
| AU2001282251A1 (en) | Lipo-viro-particle complexes, preparation method and uses | |
| Fan | Liver transplantation in Asia: Problems and practice | |
| RU2001127052A (ru) | Штамм вируса Эбола "Заир Ч-15" для проведения модельных экспериментов и приготовления диагностических и вакцинных препаратов | |
| JP2002510643A5 (OSRAM) | ||
| AU2003303889A1 (en) | Polypeptides f' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof | |
| Ruck | Human factors in the TB epidemic |